These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9641472)

  • 1. Short-term myocardial uptake of d- and l-sotalol in humans: relation to hemodynamic and electrophysiologic effects.
    Ritchie RH; Sallustio BC; Hii JT; Horowitz JD
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):876-84. PubMed ID: 9641472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between myocardial milrinone content and its acute hemodynamic and electrophysiologic effects.
    Ritchie RH; Hii JT; Horowitz JD
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):885-93. PubMed ID: 9641473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between acute myocardial uptake and hemodynamic and electrocardiographic effects of metoprolol in humans.
    Ritchie RH; Wuttke RD; Stafford I; Horowitz JD
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):57-65. PubMed ID: 7511736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial effect compartment modeling of metoprolol and sotalol: importance of myocardial subsite drug concentration.
    Ritchie RH; Morgan DJ; Horowitz JD
    J Pharm Sci; 1998 Feb; 87(2):177-82. PubMed ID: 9519150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of acute hemodynamic and electrophysiologic effects of verapamil in humans: role of myocardial drug uptake.
    Powell AC; Horowitz JD; Kertes PJ; Hasin Y; Syrjanen ML; Henry CA; Sartor DM; Louis WJ
    J Cardiovasc Pharmacol; 1990 Oct; 16(4):572-83. PubMed ID: 1706798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive and negative inotropic effects of DL-sotalol and D-sotalol in failing and nonfailing human myocardium under physiological experimental conditions.
    Holubarsch C; Schneider R; Pieske B; Ruf T; Hasenfuss G; Fraedrich G; Posival H; Just H
    Circulation; 1995 Nov; 92(10):2904-10. PubMed ID: 7586258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of the negative inotropic effects of metoprolol at short cycle lengths in humans: comparison with sotalol and verapamil.
    Ritchie RH; Zeitz CJ; Wuttke RD; Hii JT; Horowitz JD
    J Am Coll Cardiol; 2006 Sep; 48(6):1234-41. PubMed ID: 16979012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postextrasystolic potentiation in patients with ischaemic heart disease: influence of inotropic agents.
    Zhang YI; Ritchie RH; Horowitz JD
    Br J Clin Pharmacol; 1995 Jul; 40(1):25-30. PubMed ID: 8527264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparability of the electrophysiologic responses and plasma and myocardial tissue concentrations of sotalol and its d stereoisomer in the dog.
    Gomoll AW; Lekich RF; Bartek MJ; Comereski CR; Antonaccio MJ
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):204-11. PubMed ID: 1697375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the new class-III antiarrhythmic drug D-sotalol on contractile function of postischemic myocardium.
    Hoffmeister HM; Müller S; Seipel L
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):581-6. PubMed ID: 1711624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the hemodynamics effects of D-sotalol and D,L-sotalol].
    Hoffmeister HM; Seipel L
    Klin Wochenschr; 1988 May; 66(10):451-4. PubMed ID: 3398430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myocardial uptake of digoxin in humans: correlation with hemodynamic and electrocardiographic effects.
    Powell AC; Horowitz JD; Hasin Y; Syrjanen ML; Horomidis S; Louis WJ
    J Am Coll Cardiol; 1990 May; 15(6):1238-47. PubMed ID: 2329227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative beta-blocking activities and electrophysiologic actions of racemic sotalol and its optical isomers in anesthetized dogs.
    Gomoll AW; Bartek MJ
    Eur J Pharmacol; 1986 Dec; 132(2-3):123-35. PubMed ID: 2880732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic properties of sotalol and d-sotalol. A current view.
    Touboul P
    Eur Heart J; 1993 Nov; 14 Suppl H():24-9. PubMed ID: 7904935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular determinants of pro-arrhythmia proclivity of d- and l-sotalol via a multi-scale modeling pipeline.
    DeMarco KR; Yang PC; Singh V; Furutani K; Dawson JRD; Jeng MT; Fettinger JC; Bekker S; Ngo VA; Noskov SY; Yarov-Yarovoy V; Sack JT; Wulff H; Clancy CE; Vorobyov I
    J Mol Cell Cardiol; 2021 Sep; 158():163-177. PubMed ID: 34062207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute global low-flow ischemia on triggered arrhythmias in d-sotalol-induced long Q-T intervals in perfused rabbit hearts.
    Spear JF; Moore EN
    J Cardiovasc Pharmacol; 2001 Feb; 37(2):196-208. PubMed ID: 11210002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolongation of the human cardiac monophasic action potential by sotalol.
    Echt DS; Berte LE; Clusin WT; Samuelsson RG; Harrison DC; Mason JW
    Am J Cardiol; 1982 Nov; 50(5):1082-6. PubMed ID: 6127944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
    Sen L; Cui G; Sakaguchi Y; Singh BN
    J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inotropic and haemodynamic effects of d- and d,l-sotalol: comparison with other antiarrhythmics.
    Seipel L; Hoffmeister HM
    Eur Heart J; 1993 Nov; 14 Suppl H():36-40. PubMed ID: 7904937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic profiles of d-sotalol and d,l-sotalol.
    Funck-Brentano C
    Eur Heart J; 1993 Nov; 14 Suppl H():30-5. PubMed ID: 7904936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.